Atria Wealth Solutions’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-12,184
Closed -$140K 2115
2024
Q3
$140K Buy
12,184
+82
+0.7% +$941 ﹤0.01% 1832
2024
Q2
$137K Buy
12,102
+140
+1% +$1.86K ﹤0.01% 1826
2024
Q1
$172K Hold
11,962
﹤0.01% 1847
2023
Q4
$164K Buy
11,962
+96
+0.8% +$1.01K ﹤0.01% 1812
2023
Q3
$96.5K Buy
11,866
+150
+1% +$1.23K ﹤0.01% 1783
2023
Q2
$88.7K Buy
+11,716
New +$89.5K ﹤0.01% 1786
2022
Q4
Sell
-10,511
Closed -$91.8K 1898
2022
Q3
$91.8K Buy
10,511
+96
+0.9% +$997 ﹤0.01% 1651
2022
Q2
$104K Buy
+10,415
New +$105K ﹤0.01% 1528

Other funds holding PTVE

Atria Wealth Solutions's PTVE Position: Q4 2024 in Review

Atria Wealth Solutions sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q4 2024, closing a stake of 12,184 shares — an estimated $140K sold.

Atria Wealth Solutions first reported a position in PTVE in Q2 2022 and held it in 8 quarters. The position peaked at $172K in Q1 2024. 161 funds tracked by Wall St. Rank hold PTVE as of Q4 2024.

  • Atria Wealth Solutions reported no remaining Pactiv Evergreen Inc. Common stock position as of Q4 2024 after selling out during the quarter.
  • Atria Wealth Solutions sold 12,184 Pactiv Evergreen Inc. Common stock shares in Q4 2024, an estimated $140K.
  • Atria Wealth Solutions first reported a position in Pactiv Evergreen Inc. Common stock in Q2 2022 and held it in 8 quarters.
  • Atria Wealth Solutions's Pactiv Evergreen Inc. Common stock position peaked at $172K in Q1 2024.
  • 161 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q4 2024.

Based on Atria Wealth Solutions's 13F filing for Q4 2024, filed 31 Jan 2025.